Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d73a1d97981b5fc2d3ba6b231e5e7e1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06 |
filingDate |
2012-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb61f8b1379d169773c7a6ff3a6cc1b3 |
publicationDate |
2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013045990-A1 |
titleOfInvention |
Novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes |
abstract |
The present invention provides a compound of the formula below n n n n n n n n n n or a pharmaceutical salt thereof, methods of treating diabetes using the compound and a process for preparing the compound. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022211303-A1 |
priorityDate |
2011-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |